Showing results (161-170 of 221) with videos related to
Sort By:
Pageof 23
Journal of Medical Virology|August 16, 2001
Long-term persistence of antibodies induced by vaccination and safety follow-up, with the first combined vaccine against hepatitis A and B in children and adultsP Van Damme, G Leroux-Roels, B Law, et al.Vaccine|May 1, 1998
Safety and immunogenicity of a hepatitis B vaccine formulated with a novel adjuvant systemS Thoelen, P Van Damme, C Mathei, et al.Neuropharmacology|May 3, 2002
An alpha-mercaptoacrylic acid derivative (PD150606) inhibits selective motor neuron death via inhibition of kainate-induced Ca2+ influx and not via calpain inhibitionL Van den Bosch, P Van Damme, V Vleminckx, et al.Vaccine|December 28, 2018
Immunogenicity and safety of intradermal delivery of hepatitis B booster vaccine using the novel drug delivery device VAX-ID™T J S Van Mulder, K Withanage, K C L Beyers, et al.Vaccine|September 25, 2003
The cost of measles in industrialised countriesH Carabin, W J Edmunds, M Gyldmark, et al.Acta Clinica Belgica|August 18, 2012
Potential impact of policy regulation and generic competition on sales of cholesterol lowering medication, antidepressants and acid blocking agents in BelgiumJ Fraeyman, G Van Hal, H De Loof, et al.Epidemics|May 17, 2015
The social contact hypothesis under the assumption of endemic equilibrium: Elucidating the transmission potential of VZV in EuropeE Santermans, N Goeyvaerts, A Melegaro, et al.International Journal for Quality in Health Care : Journal of the International Society for Quality in Health Care|November 22, 2015
Community-acquired pneumonia (CAP) hospitalizations and deaths: is there a role for quality improvement through inter-hospital comparisons?W Aelvoet, N Terryn, A Blommaert, et al.Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|August 21, 2014
Epidemiology and outcome of invasive pneumococcal disease among adults in Belgium, 2009-2011J Verhaegen, J Flamaing, W De Backer, et al.Journal of Viral Hepatitis|May 1, 2004
Prevention of hepatitis C virus infectionM Kew, G François, D Lavanchy, et al.Pageof 23